tiprankstipranks
Trending News
More News >
Solventum Corporation (SOLV)
NYSE:SOLV
US Market
Advertisement

Solventum Corporation (SOLV) Earnings Dates, Call Summary & Reports

Compare
266 Followers

Earnings Data

Report Date
Feb 26, 2026
Before Open (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
1.49
Last Year’s EPS
1.41
Same Quarter Last Year
Moderate Buy
Based on 8 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 06, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
Solventum reported strong sales growth, successful portfolio optimization, and a transformed balance sheet, positioning the company for future growth and acquisitions. However, tariff headwinds and segment-specific challenges pose risks. Overall, the highlights significantly outweigh the lowlights, reflecting a positive outlook.
Company Guidance
During Solventum's Third Quarter 2025 Earnings Call, the company raised its annual sales growth and earnings per share (EPS) guidance, reflecting strong quarterly performance. The company reported a 2.7% organic sales growth, with contributions from its Dental Solutions and Health Information Systems (HIS) segments, driven by new product innovation and commercial specialization. Solventum is progressing towards its Long Range Plan (LRP) revenue growth targets faster than expected, with improvements in operating margins and significant reduction in debt following the sale of its Purification and Filtration business. The new Transform for the Future initiative is expected to deliver $500 million in annual savings over four years, offsetting tariff impacts and enhancing innovation. The company is also targeting tuck-in acquisitions valued under $1 billion to enhance its market presence. The guidance update includes a full-year organic sales growth at the high end of 2% to 3% and an EPS range of $5.98 to $6.08, with free cash flow guidance adjusted due to the P&F divestiture.
Sales Growth and EPS Guidance Increase
Solventum reported positive volume growth, leading to increased sales growth and EPS guidance for the year. Q3 sales were $2.1 billion, a 2.7% organic increase. The company is ramping towards long-range plan revenue growth targets faster than expected.
Portfolio Optimization Progress
The successful and timely sale of the Purification and Filtration business allowed Solventum to reduce debt, improve strategic focus, and receive credit upgrades from two rating agencies. This enhances their capability for future M&A activities.
Dental Solutions and HIS Performance
The Dental Solutions segment delivered $340 million in sales, an organic increase of 6.5%, driven by new product launches and improved service levels. The Health Information Systems segment saw a 5.6% organic sales increase, driven by strong revenue cycle management software solutions.
Transform for the Future Initiative
The new initiative aims to reshape Solventum’s cost structure, improve operational efficiency, and drive innovation. It is expected to deliver annual savings of approximately $500 million once fully implemented.
Debt Reduction and Strong Balance Sheet
Solventum paid down $2.7 billion of debt in Q3 post-divestiture of the Purification and Filtration business. The transformed balance sheet adds flexibility for future capital allocation and tuck-in acquisitions.

Solventum Corporation (SOLV) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

SOLV Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 26, 2026
2025 (Q4)
1.49 / -
1.41
Nov 06, 2025
2025 (Q3)
1.43 / 1.50
1.64-8.54% (-0.14)
Aug 07, 2025
2025 (Q2)
1.45 / 1.69
1.568.33% (+0.13)
May 08, 2025
2025 (Q1)
1.21 / 1.34
2.08-35.58% (-0.74)
Feb 27, 2025
2024 (Q4)
1.31 / 1.41
2.311-38.99% (-0.90)
Nov 07, 2024
2024 (Q3)
1.39 / 1.64
2.664-38.44% (-1.02)
Aug 08, 2024
2024 (Q2)
1.50 / 1.56
1.859-16.08% (-0.30)
May 09, 2024
2024 (Q1)
1.75 / 2.08
1.69622.64% (+0.38)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

SOLV Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 06, 2025
$66.28$71.52+7.91%
Aug 07, 2025
$71.95$73.39+2.00%
May 08, 2025
$66.63$70.23+5.40%
Feb 27, 2025
$83.44$79.75-4.42%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Solventum Corporation (SOLV) report earnings?
Solventum Corporation (SOLV) is schdueled to report earning on Feb 26, 2026, Before Open (Confirmed).
    What is Solventum Corporation (SOLV) earnings time?
    Solventum Corporation (SOLV) earnings time is at Feb 26, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is SOLV EPS forecast?
          SOLV EPS forecast for the fiscal quarter 2025 (Q4) is 1.49.

            Solventum Corporation (SOLV) Earnings News

            MMM Earnings: 3M Delivers Robust Q2 Results, Raises Forecast
            Premium
            Market News
            MMM Earnings: 3M Delivers Robust Q2 Results, Raises Forecast
            1y ago
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis